Insilico Medicine Hong Kong Limited
Clinical trials sponsored by Insilico Medicine Hong Kong Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could an AI-Designed pill take on Hard-to-Treat cancers? Results expected Nov 2026 (estimated)
- New drug ISM8969 enters first human safety tests Results expected Jan 2027 (estimated)
- New pill aims to tame ulcerative colitis Flare-Ups Results expected Aug 2027 (estimated)
- New pill shows promise in early trial for tough cancers Results expected Aug 2027 (estimated)